SEC Filing Details

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Mar 4, 2019
Document Date
Dec 17, 2018
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE